Drug intelligence / Profile preview

adipose-derived mesenchymal stem cells (Shandong Province Qilu Stem Cells Engineering)

Development stage: Unknown
Lead developer: Shandong Qilu Stem Cell Engineering
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Local Injection

Overview

Adipose-derived mesenchymal stem cells (AD-MSCs) developed by Shandong Province Qilu Stem Cells Engineering are a type of multipotent stem cell therapy derived from adipose (fat) tissue. These cells are characterized by their ability to differentiate into various cell lineages and their potent immunomodulatory and regenerative properties. In a clinical context, they are investigated for their potential to promote tissue repair, reduce inflammation, and modulate immune responses. While the developer, Shandong Province Qilu Stem Cells Engineering, has several registered clinical research projects for umbilical cord-derived MSCs (UC-MSCs), their AD-MSC platform is offered as part of their clinical services and research capabilities, though specific late-stage clinical trial data for named indications is less prominently documented compared to their UC-MSC pipeline.

Other names: adipose-derived mesenchymal stem cellsAD-MSCs

Beyond the preview

Go deeper on adipose-derived mesenchymal stem cells (Shandong Province Qilu Stem Cells Engineering).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on adipose-derived mesenchymal stem cells (Shandong Province Qilu Stem Cells Engineering).

Explore the full profile